Changeflow GovPing Healthcare & Life Sciences Biologically Active Conjugate Patent, D&D Pharm...
Routine Rule Added Final

Biologically Active Conjugate Patent, D&D Pharmatech

Favicon for changeflow.com EPO Patent Bulletin - Peptides (C07K)
Published
Detected
Email

Summary

The EPO published European patent application EP4252780A1 for D&D Pharmatech Inc. on April 15, 2026, covering a biologically active material conjugate with a biotin moiety, fatty acid moiety, or combination thereof. The application lists inventors SHIN Jae hee, LIM Sung Mook, and PARK Eun Ji, with classifications spanning A61K 47/54, A61K 38/00, A61K 38/16, A61K 9/00, A61K 38/26, A61K 47/55, and C07K 14/605. The patent is designated across 38 European and Patent Cooperation Treaty states including Germany, France, the United Kingdom, Italy, Spain, the Netherlands, Sweden, and 31 additional countries.

“BIOLOGICALLY ACTIVE MATERIAL CONJUGATE HAVING BIOTIN MOIETY, FATTY ACID MOIETY, OR COMBINATION THEREOF COUPLED THERETO”

EPO , verbatim from source
Published by EPO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors EPO Patent Bulletin - Peptides (C07K) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 58 changes logged to date.

What changed

The EPO published patent application EP4252780A1 for D&D Pharmatech Inc. covering a biologically active material conjugate with a biotin moiety, fatty acid moiety, or combination. The application was published April 15, 2026 and designates 38 states across Europe and the Patent Cooperation Treaty system.

Parties monitoring the pharmaceutical and biotechnology space should note this publication as it establishes priority dates and publication of the technical disclosure for this conjugate technology. Third parties have an opportunity to review the published application and assess potential Freedom to Operate implications.

Archived snapshot

Apr 25, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← EPO Patent Bulletin

BIOLOGICALLY ACTIVE MATERIAL CONJUGATE HAVING BIOTIN MOIETY, FATTY ACID MOIETY, OR COMBINATION THEREOF COUPLED THERETO

Publication EP4252780A1 Kind: A1 Apr 15, 2026

Applicants

D&D Pharmatech Inc.

Inventors

SHIN, Jae hee, LIM, Sung Mook, PARK, Eun Ji

IPC Classifications

A61K 47/54 20170101AFI20260311BHEP A61K 38/00 20060101ALI20260311BHEP A61K 38/16 20060101ALI20260311BHEP A61K 9/00 20060101ALI20260311BHEP A61K 38/26 20060101ALI20260311BHEP A61K 47/55 20170101ALI20260311BHEP C07K 14/605 20060101ALI20260311BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Get daily alerts for EPO Patent Bulletin - Peptides (C07K)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from EPO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
EPO
Published
April 15th, 2026
Instrument
Rule
Branch
International
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
EP4252780A1

Who this affects

Applies to
Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Patent publication Biotech research Pharmaceutical development
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Healthcare

Get alerts for this source

We'll email you when EPO Patent Bulletin - Peptides (C07K) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!